Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
A series of aromatic amidino compounds were investigated for their inhibitory effect on platelet agglutination and platelet aggregation. Agglutination of fresh or fixed platelets was produced by bovine plasma or by human plasma in combination with ristocetin, while aggregation of fresh platelets was induced by ADP, thrombin or collagen. Highly effective inhibitors were found for both types of platelet clumping, but there was no parralelism between the inhibitory activities in the two test system. 5-(5-amidino-2-benzimidazolyl)-2-(4-hydroxybenzene)benzimidazole suppressed agglutination exclusively. Pentamidine, on the other hand, strongly blocked the aggregation reaction, but did not interfere with agglutination, even at high concentrations. Compounds which inhibited aggregation also prevented the liberation of serotonin from the platelets.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000371:Agglutination / Q000187:drug effects*; D000578:Amidines / Q000494:pharmacology*; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D002417:Cattle; D003094:Collagen / Q000494:pharmacology; D006801:Humans; D010419:Pentamidine / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D012310:Ristocetin / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013917:Thrombin / Q000494:pharmacology
D000578:Amidines; D001562:Benzimidazoles; D012310:Ristocetin; D012701:Serotonin; D000244:Adenosine Diphosphate; D010419:Pentamidine; D003094:Collagen; D013917:Thrombin